IGI Laboratories, Inc.
105 Lincoln Avenue
Buena, New Jersey 08310
March 25, 2011
Via EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Johnny Gharib, Division of Corporation Finance
Jeffrey Riedler, Assistant Director
Re:
IGI Laboratories, Inc.
Registration Statement on Form S-3
Registration No. 333-171446
Dear Sir or Madam:
IGI Laboratories, Inc., a Delaware corporation (the “Company”), hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective date of the Company’s Registration Statement on Form S-3, Registration No. 333-171446 (the “Registration Statement”), be accelerated so that the Company’s Registration Statement will become effective, at 4:15 p.m. Eastern Standard Time on Monday, March 28, 2011, or as soon thereafter as practicable.
In connection with this acceleration request, the Company acknowledges that:
•
should the U.S. Securities and Exchange Commission (“Commission”), or its Staff (“Staff”) acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the Registration Statement’s disclosures; and
•
the Company will not assert the declaration of the Registration Statement’s effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.